Taguchi Kazuhiro, Ishiyama Kohei, Ide Kentaro, Ohira Masahiro, Tahara Hiroyuki, Ohdan Hideki
Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima City, Hiroshima, Japan.
Institute for Clinical Research, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima, Japan.
Am J Case Rep. 2019 Jul 9;20:980-987. doi: 10.12659/AJCR.916717.
BACKGROUND Heparin-induced thrombocytopenia (HIT) is the development of thrombocytopenia caused by exposure to heparin. Here, we report the case of a 58-year-old male with HIT who then underwent a successful simultaneous liver-kidney transplantation (SLKT). CASE REPORT The patient had end-stage hepatitis due to a hepatitis C virus (HCV) infection and was on hemodialysis due to nephropathy related to HCV. Furthermore, he was diagnosed with HIT caused by the administration of heparin for hemodialysis during these treatments. Fortunately, there was no evidence of thromboses and HIT antibody converted negative immediately. Four years after the occurrence of HIT, SLKT was performed for liver and kidney failure. Although the donor was heparinized, the donor grafts were flushed on a backtable by an organ preservation solution without heparin to reduce residual heparin. The subsequent transplantation was uneventful. After the operation, anticoagulation with argatroban, a direct thrombin inhibitor, was started instead of heparin. In the postoperative course, neither thrombosis nor graft dysfunction occurred. CONCLUSIONS SLKT in a patient who had a history of HIT could be performed safely.
背景 肝素诱导的血小板减少症(HIT)是因接触肝素而发生的血小板减少症。在此,我们报告一例58岁男性HIT患者,该患者随后成功接受了肝肾联合移植(SLKT)。病例报告 该患者因丙型肝炎病毒(HCV)感染导致终末期肝炎,因与HCV相关的肾病而接受血液透析。此外,他在这些治疗期间因血液透析使用肝素而被诊断为HIT。幸运的是,没有血栓形成的证据,且HIT抗体立即转为阴性。HIT发生四年后,因肝肾功能衰竭进行了SLKT。尽管供体使用了肝素,但供体移植物在手术台上用不含肝素的器官保存液冲洗,以减少残留肝素。随后的移植过程顺利。术后,开始使用直接凝血酶抑制剂阿加曲班进行抗凝,而不是肝素。在术后过程中,既没有发生血栓形成,也没有出现移植物功能障碍。结论 有HIT病史的患者可以安全地进行SLKT。